Orbimed Advisors - IMMUNOMEDICS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$26,860,000
+136.7%
757,900
-7.4%
0.38%
+114.8%
Q2 2019$11,348,000
-86.2%
818,200
-80.8%
0.18%
-86.1%
Q1 2019$82,034,000
+13.4%
4,270,403
-15.7%
1.27%
-5.0%
Q4 2018$72,312,000
-19.8%
5,067,403
+17.1%
1.34%
+23.1%
Q3 2018$90,164,000
-23.0%
4,328,573
-12.5%
1.09%
-22.2%
Q2 2018$117,038,000
+40.3%
4,944,573
-13.4%
1.40%
+35.0%
Q1 2018$83,434,000
-39.0%
5,710,774
-32.5%
1.03%
-40.2%
Q4 2017$136,742,000
-2.2%
8,461,727
-15.4%
1.73%
+29.5%
Q3 2017$139,755,000
+221.1%
9,996,816
+102.8%
1.34%
+193.0%
Q2 2017$43,523,000
+445.9%
4,928,958
+300.0%
0.46%
+406.7%
Q1 2017$7,972,000
-42.9%
1,232,100
-67.6%
0.09%
-49.4%
Q4 2016$13,953,000
+12.9%
3,802,0000.0%0.18%
+26.2%
Q3 2016$12,357,000
+40.1%
3,802,0000.0%0.14%
+53.3%
Q2 2016$8,821,000
-7.2%
3,802,0000.0%0.09%
-8.0%
Q1 2016$9,505,000
-18.6%
3,802,0000.0%0.10%
-5.7%
Q4 2015$11,672,000
+104.2%
3,802,000
+14.4%
0.11%
+82.8%
Q3 2015$5,716,0003,323,0000.06%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders